Amgen Canada is proud to share an online video series they have developed on biosimilars. The videos were released today in the digital version of The Globe & Mail. For the past several months, Amgen has worked with The Globe & Mail to create these online videos that cover the key issues on biosimilars. Participants included Amgen Canada’s Karen Burke, who provided perspective on
Year: 2013
Canadian Cancer Survivor Network launches dedicated breast cancer Twitter page!
To celebrate Breast Cancer Awareness Month and to our organization's involvement in the battle against breast cancer, we have launched a dedicated breast cancer Twitter which we invite you to follow: @BestBreastNews . If you have breast news, send it to bestbreastnews@gmail.com and we will both post it on this website and tweet it!
Albertan men and women with advanced prostate and breast cancer deserve access to bone-targeted therapies
The Canadian Cancer Survivor Network is deeply concerned that men and women living in Alberta who have advanced prostate and breast cancer that has spread to their bones do not have public access to treatments that can reduce the risk of serious bone complications. Men and women whose cancer has spread, or metastasised, to their bones are at risk of developing serious, debilitating complications
Canadian Cancer Survivor Network calls for increased training and closer oversight and supervision of radiologists
The approximately 3,500 patients who relied on results of CT scans and mammograms conducted by Trillium Health now called into question have every right to be both worried and outraged. Canadians trust that mammography and CT scans will help them learn whether they are in good health or whether an abnormal scan requires further investigation, leading to an early diagnosis and treatment of cancer with
Ontario women with advanced breast cancer deserve access to newest bone-targeted therapies
The Canadian Cancer Survivor Network is deeply concerned that women living in Ontario who have breast cancer that has spread to their bones do not have public access to all bone-targeted treatments that can reduce the risk of serious bone complications. Older treatments, which may not be suitable for all patients, are currently the only options available. The newer class of treatments, RANK-Ligand inhibitors, is
CCSN calls for timely access to targeted bone therapies for patients with advanced breast and prostate cancer in British Columbia
Within British Columbia, the newest bone-targeting agent was recently listed on its formulary for men and women with advanced prostate and breast cancer that has spread to their bones, who are considered palliative. While the Canadian Cancer Survivor Network thinks that this is good news for these patients and a positive step forward, other men and women with advanced prostate and breast cancer that has